Holdings of Goldman Sachs Future Health Care Equity ETF
Goldman Sachs ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 20.1M $ including 19.8M $ in equities, 98.5 %
- Positions
- 41 in 9 countries
- Top ten
- 57.3 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 2,417 | 2.7M $ | 13.28 % |
| 2 | Johnson & Johnson | 7,204 | 1.6M $ | 8.07 % |
| 3 | Merck & Co Inc | 10,073 | 1.2M $ | 5.94 % |
| 4 | GUARDANT HEALTH INC | 8,286 | 1.1M $ | 5.34 % |
| 5 | AstraZeneca PLC | 5,234 | 973.8K $ | 4.84 % |
| 6 | Thermo Fisher Scientific Inc | 1,847 | 909.7K $ | 4.52 % |
| 7 | Argenx SE | 979 | 818.4K $ | 4.07 % |
| 8 | Intuitive Surgical Inc | 1,849 | 785.2K $ | 3.90 % |
| 9 | Boston Scientific Corp | 15,740 | 760.4K $ | 3.78 % |
| 10 | Hoya Corp | 4,173 | 709.9K $ | 3.53 % |
| 11 | Edwards Lifesciences Corp | 6,939 | 600K $ | 2.98 % |
| 12 | Lonza Group AG | 879 | 562.9K $ | 2.80 % |
| 13 | Dexcom Inc | 7,621 | 562K $ | 2.79 % |
| 14 | Agilent Technologies Inc | 4,105 | 556.4K $ | 2.77 % |
| 15 | Roivant Sciences Ltd | 16,036 | 480.9K $ | 2.39 % |
| 16 | Cencora Inc | 1,750 | 471.4K $ | 2.34 % |
| 17 | Apogee Therapeutics Inc | 4,823 | 396.2K $ | 1.97 % |
| 18 | ROYALTY PHARMA PLC | 6,370 | 355.2K $ | 1.77 % |
| 19 | Penumbra Inc | 1,015 | 323.1K $ | 1.61 % |
| 20 | Mettler-Toledo International Inc | 271 | 319.9K $ | 1.59 % |
| 21 | Vertex Pharmaceuticals Inc | 667 | 298.5K $ | 1.48 % |
| 22 | CYTOKINETICS INC | 3,663 | 281.2K $ | 1.40 % |
| 23 | IONIS PHARMACEUTICALS INC | 3,614 | 276.5K $ | 1.37 % |
| 24 | Xenon Pharmaceuticals Inc | 4,977 | 272.4K $ | 1.35 % |
| 25 | UnitedHealth Group Inc | 715 | 271.9K $ | 1.35 % |
| 26 | Repligen Corp | 2,038 | 252.6K $ | 1.26 % |
| 27 | Insmed Inc | 2,081 | 222.5K $ | 1.11 % |
| 28 | Galderma Group AG | 1,034 | 220.4K $ | 1.10 % |
| 29 | Madrigal Pharmaceuticals Inc | 430 | 213.8K $ | 1.06 % |
| 30 | REVOLUTION MEDICINES INC | 1,069 | 168.3K $ | 0.84 % |
| 31 | CG ONCOLOGY INC | 2,432 | 151.5K $ | 0.75 % |
| 32 | Bridgebio Pharma Inc | 2,214 | 146.7K $ | 0.73 % |
| 33 | Quest Diagnostics Inc | 741 | 144.4K $ | 0.72 % |
| 34 | Rhythm Pharmaceuticals Inc | 1,538 | 135.8K $ | 0.68 % |
| 35 | Alkermes PLC | 2,703 | 114K $ | 0.57 % |
| 36 | Sartorius Stedim Biotech | 533 | 110.8K $ | 0.55 % |
| 37 | Praxis Precision Medicines Inc | 316 | 110.6K $ | 0.55 % |
| 38 | Definium Therapeutics Inc | 4,214 | 101.9K $ | 0.51 % |
| 39 | Spyre Therapeutics Inc | 960 | 70.6K $ | 0.35 % |
| 40 | Insulet Corp | 398 | 57.7K $ | 0.29 % |
| 41 | STRUCTURE THERAPEUTICS INC | 1,008 | 39.7K $ | 0.20 % |
Sector breakdown
- Health care 71.5 %
- Unattributed 28.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 87.0 %
- GBP 4.9 %
- CHF 4.0 %
- JPY 3.6 %
- EUR 0.6 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 78.5 %
- United Kingdom 4.9 %
- Netherlands 4.1 %
- Switzerland 4.0 %
- Japan 3.6 %
- Bermuda 2.4 %
- Canada 1.4 %
- Ireland 0.6 %
- France 0.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 32 | 15.5M $ | 78.48 % |
| 2 | United Kingdom | 1 | 973.8K $ | 4.92 % |
| 3 | Netherlands | 1 | 818.4K $ | 4.13 % |
| 4 | Switzerland | 2 | 783.3K $ | 3.95 % |
| 5 | Japan | 1 | 709.9K $ | 3.58 % |
| 6 | Bermuda | 1 | 480.9K $ | 2.43 % |
| 7 | Canada | 1 | 272.4K $ | 1.37 % |
| 8 | Ireland | 1 | 114K $ | 0.58 % |
| 9 | France | 1 | 110.8K $ | 0.56 % |
Cite this page
Titelia. "Holdings of Goldman Sachs Future Health Care Equity ETF". https://titelia.com/en/funds/S000072296